Hansa Biopharma to host conference call to provide half year results for January-June 2023 and a Business Update

To participate in the telephone conference, please use the dial-in details provided below: To participate in the telephone conference, please use the dial-in details provided below: Sweden : +46 10 884 80 16 United Kingdom : +44 20 3936 2999 United States : +1 646 664 1960 Participant access code: 323180 The webcast will be available onhttps://events.q4inc.com/attendee/206699686 Financial calendar and events 2023 July 18, 2023            William Blair Conference...

To participate in the telephone conference, please use the dial-in details provided below:

Sweden: +46 10 884 80 16

United Kingdom: +44 20 3936 2999

United States: +1 646 664 1960

Participant access code: 323180

The webcast will be available on https://events.q4inc.com/attendee/206699686

Financial calendar and events 2023

July 18, 2023            William Blair Conference Transitioning Biotech Breakthroughs to Commercial Success (virtual)

July 20, 2023            Half-year Report for January-June 2023

Aug 23, 2023            Carnegie non-deal road show, Stockholm

Aug 24, 2023            Erik Penser Company Day, Stockholm

Aug 30-31, 2023       Cowen US non-deal road show

Sept 6-7, 2023          CITI Annual BioPharma Conference, Boston

Sept 11, 2023           HC Wainwright Annual Global Investment Conference, NYC

Sept 11-12, 2023      MorganStanley Global Healthcare Conference, NYC

Sept 14, 2023           Pareto Annual Healthcare Conference, Stockholm

Sept 14, 2023           Erik Penser Company Day, Malmö

Oct 2, 2023              Redeye: Autoimmune and inflammatory disease, Stockholm

Oct 12, 2023            Redeye: Afterwork, Malmö

Oct 19, 2023            Interim Report for January-September 2023

Nov 21, 2023            SEB Healthcare Seminar 2023, Stockholm

Nov 22, 2023           Ökonomisk Ugebrev Life Science Event, Copenhagen

For further information, please contact:
Klaus Sindahl, VP Head of Investor Relations
M: +46 (0) 709–298 269
E: klaus.sindahl@hansabiopharma.com

Stephanie Kenney, VP Global Corporate Affairs
M: +1 (484) 319 2802
E: stephanie.kenney@hansabiopharma.com

The following files are available for download:

 

View original content:https://www.prnewswire.co.uk/news-releases/hansa-biopharma-to-host-conference-call-to-provide-half-year-results-for-january-june-2023-and-a-business-update-301870873.html